Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRB2 | P62993 | 1/20 | 0.36 |
| ▸ | ACE | P12821 | 2/20 | 0.34 |
| ▸ | MME | P08473 | 1/20 | 0.33 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.33 |
| ▸ | GLP1R | P43220 | 1/20 | 0.31 |
| ▸ | SCTR | P47872 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.30 |
| ▸ | CPB1 | P15086 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29837202 | 0.91 | GLP1R (0.36) | GRB2GLP1RSCTR | |
| SCHEMBL31388786 | 0.90 | GRB2 (0.37) | GRB2MMEGLP1RSCTR | |
| SCHEMBL29545820 | 0.85 | CTSC (0.33) | — | |
| SCHEMBL9665035 | 0.84 | MME (0.35) | MME | |
| SCHEMBL2958250 | 0.84 | MME (0.35) | MME | |
| SCHEMBL23598223 | 0.84 | MME (0.35) | MME | |
| SCHEMBL2962003 | 0.84 | MME (0.35) | MME | |
| SCHEMBL2958246 | 0.84 | MME (0.35) | MME | |
| SCHEMBL9665040 | 0.84 | MME (0.35) | MME | |
| Hydrochloric Acid SCHEMBL6933795 | 0.83 | MME (0.34) | MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4745153-A1 | GLP-1, GIP AND GCG RECEPTOR TRIAGONIST AND USE THEREOF | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) | 2026-05-20 | — | — | EP | disclosed |
| WO-2025016303-A1 | GLP-1, GIP AND GCG RECEPTOR TRIAGONIST AND USE THEREOF | 北京拓界生物医药科技有限公司 | 2025-01-23 | — | — | WO | disclosed |